Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastoma
Yael Kusne(WinnMed), Sourav Ghosh(Yale University), Edward K. Mandell(Yale University), Eugenio Antonio Carrera Silva(Academia Nacional de Medicina), Christopher Hulme(University of Arizona), Nader Sanai(St. Joseph's Hospital and Medical Center), Anthony S. Perry(The University of Texas MD Anderson Cancer Center), Michael E. Berens(Translational Genomics Research Institute), Kenneth Aldape(National Institutes of Health), Andrea Emilse Errasti(Consejo Nacional de Investigaciones Científicas y Técnicas), Weiwei Yang(Center for Excellence in Molecular Cell Science), Elisabeth J. Rushing(University Hospital of Zurich), Carla V. Rothlin(Yale University), Joseph C. Loftus(Mayo Clinic in Arizona), Zhimin Lu(Shandong Sport University), Justin Dietrich(University of Arizona), Daniel Gibbs(Institute of Human Genetics)
Cited by 46
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k